CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-24 | McWilliams David Director | Grant or award · Stock Options | +61,984 | 123,968 | ||
| 2022-06-22 | McWilliams David Director | Grant or award · Stock Options | +61,984 | 61,984 | ||
| 2021-12-14 | McWilliams David Director | Purchase | +200 | $27.56 | $6K | 620,301 |
| 2020-11-20 | McWilliams David Director | Purchase | +1,500 | $5.40 | $8K | 620,101 |
| 2020-09-29 | McWilliams David Director | Exercise or conversion | +152,604 | 599,583 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion | +7,663 | 607,246 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion | +3,746 | 610,992 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion | +7,609 | 618,601 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion · Series A Preferred Stock | −152,604 | 0 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion · Series B Preferred Stock | −7,663 | 0 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion · Series C Preferred Stock | −3,746 | 0 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion · Series D Preferred Stock | −6,555 | 0 | ||
| 2020-09-29 | McWilliams David Director | Other acquisition · Series D Preferred Stock | +1,054 | 1,054 | ||
| 2020-09-29 | McWilliams David Director | Exercise or conversion · Series D Preferred Stock | −1,054 | 0 | ||
| 2020-09-29 | McWilliams David Director | Purchase | +2,608 | $5.75 | $15K | 446,979 |
Page 1 of 1 · 15 trades